- Messages
- 8,934
- Type of diabetes
- Type 1
- Treatment type
- Other
Whilst reviewing NICE guidelines for Diabetes care. I stumbled upon an interesting technology appraisal that's underway. The nattily named
Type 1 diabetes: Integrated sensor-augmented pump therapy systems for managing blood glucose levels (The MiniMed Paradigm Veo System and the Vibe and G4 PLATINUM CGM system
What's probably most telling about this is that the systems they've named in the title are the out of date versions (note that the Minimed 640G is clearly a very different kettle of fish) and that in the notes, the stakeholder manufacturers are Medtronic, Dexcom, and Animas only. Roche, Omnipod and Cellnovo are not participating suggesting their systems are still very much in the future.
Nothing published as yet, but one to keep an eye on I think...
Type 1 diabetes: Integrated sensor-augmented pump therapy systems for managing blood glucose levels (The MiniMed Paradigm Veo System and the Vibe and G4 PLATINUM CGM system
What's probably most telling about this is that the systems they've named in the title are the out of date versions (note that the Minimed 640G is clearly a very different kettle of fish) and that in the notes, the stakeholder manufacturers are Medtronic, Dexcom, and Animas only. Roche, Omnipod and Cellnovo are not participating suggesting their systems are still very much in the future.
Nothing published as yet, but one to keep an eye on I think...